Pitavastatin Sodium is a potent HMG-CoA reductase inhibitor belonging to the statin class of medications, primarily prescribed to manage hyperlipidemia and reduce the risk of cardiovascular events, including… Read more
Pitavastatin Sodium is a potent HMG-CoA reductase inhibitor belonging to the statin class of medications, primarily prescribed to manage hyperlipidemia and reduce the risk of cardiovascular events, including myocardial infarction and stroke. Analytical laboratories require high-quality reference standards of the active pharmaceutical ingredient, along with its associated degradation products, synthetic impurities, and stable isotope labelled compounds, to support rigorous quality control processes. These materials are essential for conducting precise impurity profiling, method validation, and chromatographic separation studies. By utilizing specific related compounds, such as the Pitavastatin formyl impurity, researchers can ensure compliance with regulatory standards for purity and assay testing. Access to a comprehensive range of these certified reference standards facilitates the accurate identification and quantification of potential contaminants, ensuring the safety and efficacy of the final pharmaceutical product throughout its manufacturing lifecycle.